Regenerative Medicine Perspectives in Polycystic Ovary Syndrome
- 22 March 2021
- book chapter
- Published by Springer Nature
- p. 125-141
Abstract
Polycystic ovary syndrome (PCOS) is the most common gynecologic endocrine disorder in women between the ages of 15 and 40, with uncertain etiology. It is mostly presented with hyperandrogenism and insulin resistance along with a variety of comorbidities that significantly reduce a patient’s quality of life. Many disturbed metabolic pathways are correlated with PCOS. Moreover, it is evident that there is a strong genetic factor for PCOS. Indeed, several altered gene expressions have been found in PCOS subjects, but the exact genetic origins are still unclear. The major treatment options such as pharmacological treatments are to improve the symptoms. In addition, surgical procedures (Bariatric surgery and assisted reproductive technologies) can be used to treat some of the patient’s complications and reduce their severity. Generally, using pharmacological agents for a long period of time can increase the risk of adverse effects. Moreover, surgical options may have high-risk consequences. Herein, there is an undeniable need for a different multidisciplinary approach to PCOS. Regenerative medicine with the help of stem cells can develop a worthy alternative approach for the treatment of PCOS. Furthermore, animal models can provide valuable knowledge of genetic alterations and metabolic pathway disturbances in PCOS. They can also be used for testing novel treatments in pre-clinical stages. Therein, the current knowledge of PCOS and investigation about the potential role of regenerative medicine in developing new and more efficient treatments for PCOS are summarized here.Keywords
This publication has 69 references indexed in Scilit:
- Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting macrophage infiltrationInternational Immunopharmacology, 2013
- Reversal of Type 1 Diabetes in Mice by Brown Adipose Tissue TransplantDiabetes, 2012
- Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndromeFertility and Sterility, 2011
- Low-grade chronic inflammation in the peripheral blood and ovaries of women with polycystic ovarian syndromeEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2011
- Linkage of regulators of TGF‐β activity in the fetal ovary to polycystic ovary syndromeThe FASEB Journal, 2011
- Mesenchymal Stem Cells: Mechanisms of InflammationAnnual Review of Pathology: Mechanisms of Disease, 2011
- Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trialAmerican Journal of Physiology-Endocrinology and Metabolism, 2011
- PCOS Forum: research in polycystic ovary syndrome today and tomorrowClinical Endocrinology, 2010
- Pregnancy in a woman with polycystic ovary syndrome and myelodysplastic syndrome (in the form of refractory anemia) treated with allogeneic hemopoietic stem-cell transplantation (alloHSCT)Gynecological Endocrinology, 2009
- Paracrine Action Enhances the Effects of Autologous Mesenchymal Stem Cell Transplantation on Vascular Regeneration in Rat Model of Myocardial InfarctionThe Annals of Thoracic Surgery, 2005